CTSA INFRASTRUCTURE FOR AIDS RESEARCH

CTSA 艾滋病研究基础设施

• 批准号: 8366091
• 负责人: DAVID S STEPHENS
• 金额: $ 29.36万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-06-01 至 2012-06-26
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8366091
• 关键词: Acquired Immunodeficiency Syndrome; Clinical Sciences; Institutes; Research; Research Infrastructure; Translational Research

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. In response to the national effort to develop, improve, and deliver clinical and translational science, the leadership of Emory University challenged both faculty and the administration to transform clinical and translational research within the University and its numerous components and affiliates. With ongoing collaborations in heath-care, education, and interdisciplinary research, Emory also chose to engage two of its close academic partners in metropolitan Atlanta - Morehouse School of Medicine (MSM) and Georgia Institute of Technology (GA Tech) to form the Atlanta Clinical and Translational Science Institute (Atlanta-CTSI). This strategic multi-institutional alliance offered compelling and unique advantages. Emory is one of the nation's leading healthcare and academic research institutions, ranking 19th nationally in NIH funded research; GA Tech is a national leader in biomedical engineering and the application of innovative systems engineering to health care solutions; and MSM is a historically black medical school recognized as a national leader in expanding the ethnic diversity of biomedical research, dedicated to community engagement in efforts to eliminate health disparities and serving as a pipeline for training minority investigators. The established partnerships and diverse faculty enable the Atlanta-CTSI to combine strong clinical, translational, training and basic discovery programs at Emory with the health disparities, training and community outreach focus of MSM together with the engineering and bioinformatics achievements of GA Tech. The Atlanta-CTSI is a model designed to harness the scientific, technological, and clinical advantages of these institutions around the major aims of discovery, training, and community engagement to create a new city wide home for clinical and translational research. Other new programs resulting from the synergistic partnership include an innovative pilot projects program PiCo-TraCS, integrated clinical interactions and biomedical informatics networks (CIN and BIN), creation of a technology "pipeline" and Academy for Translational Methods Development, a bioinformatics Leapfrog initiative, a facilitating Office of Human Studies Research, creative K30/K12 and T32 programs, and an outstanding community engagement program. The institutional support for the Atlanta-CTSI is exceptional. The Atlanta- CTSI utilizes the complementary strengths of Emory, MSM, and GA Tech and other GA institutions to promote the discipline of clinical and translational science and to improve the healthcare of our community.

该子项目代表了 CTSA 资金百分比的估计 被用于广泛的研究领域（艾滋病研究、儿科研究或 临床试验）。 列出的总成本只是 CTSA 金额的估计值 该研究领域的基础设施，而不是直接资助 NCRR 向子项目或子项目人员提供的补助金。 为了响应国家发展、改进和提供临床和转化科学的努力，埃默里大学的领导层向教职员工和行政部门提出挑战，要求改变大学及其众多组成部分和附属机构内的临床和转化研究。通过在医疗保健、教育和跨学科研究方面的持续合作，埃默里大学还选择与亚特兰大都会区的两个密切学术合作伙伴——莫尔豪斯医学院 (MSM) 和佐治亚理工学院 (GA Tech) 合作，组建亚特兰大临床中心和转化科学研究所（亚特兰大-CTSI）。这种战略性多机构联盟提供了引人注目的独特优势。埃默里大学是美国领先的医疗保健和学术研究机构之一，在 NIH 资助的研究中排名全国第 19 位； GA Tech 是生物医学工程以及创新系统工程在医疗保健解决方案应用方面的全国领先者； MSM 是一所历史悠久的黑人医学院，被公认为扩大生物医学研究种族多样性的国家领导者，致力于社区参与消除健康差距的努力，并作为培训少数族裔研究人员的渠道。已建立的合作伙伴关系和多元化的师资队伍使亚特兰大-CTSI能够将埃默里大学强大的临床、转化、培训和基础发现项目与 MSM 的健康差异、培训和社区外展重点以及 GA Tech 的工程和生物信息学成就结合起来。亚特兰大-CTSI 是一个模型，旨在围绕发现、培训和社区参与的主要目标，利用这些机构的科学、技术和临床优势，为临床和转化研究创建一个新的全市范围的家园。协同合作伙伴关系产生的其他新项目包括创新试点项目 PiCo-TraCS、综合临床相互作用和生物医学信息学网络（CIN 和 BIN）、创建技术“管道”和转化方法开发学院（一项生物信息学 Leapfrog 计划），一个促进人类研究办公室、创造性的 K30/K12 和 T32 项目以及出色的社区参与项目。亚特兰大-CTSI 的机构支持非常出色。亚特兰大- CTSI 利用埃默里大学、MSM、GA Tech 和其他 GA 机构的互补优势来促进临床和转化科学学科的发展，并改善我们社区的医疗保健。